CIK 0001819576
- Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851710962
- Phone
- +1 919-328-4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,616,882
- in 14 filings, $3.0M under 10b5-1 plans
Net −$10,616,882. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-12 | Kaseta Michael CFO and COO | Sale 10b5-1 | −3,136 | $14.58 | $46K | 315,045 |
| 2024-04-12 | JEFFS ROGER Chief Executive Officer | Sale 10b5-1 | −8,360 | $14.58 | $122K | 826,985 |
| 2024-04-12 | Adair Jason Chief Business Officer | Sale 10b5-1 | −1,189 | $14.58 | $17K | 111,537 |
| 2024-04-11 | Adair Jason Chief Business Officer | Exercise or conversion 10b5-1 | +3,906 | 112,546 | ||
| 2024-04-11 | Adair Jason Chief Business Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −3,906 | 42,969 | ||
| 2024-03-18 | Adair Jason Chief Business Officer | Exercise or conversion 10b5-1 | +260 | 113,297 | ||
| 2024-03-18 | Adair Jason Chief Business Officer | Sale 10b5-1 | −4,581 | $15.82 | $72K | 108,716 |
| 2024-03-18 | Adair Jason Chief Business Officer | Sale 10b5-1 | −76 | $15.50 | $1K | 108,640 |
| 2024-03-18 | Adair Jason Chief Business Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −260 | 0 | ||
| 2024-03-18 | Schundler Russell General Counsel | Sale 10b5-1 | −715 | $15.82 | $11K | 496,025 |
| 2024-03-18 | Schundler Russell General Counsel | Sale 10b5-1 | −7,938 | $15.82 | $126K | 488,087 |
| 2024-03-18 | Moomaw Scott Chief Commercial Officer | Sale 10b5-1 | −6,108 | $15.82 | $97K | 153,466 |
| 2024-03-18 | Kaseta Michael CFO and COO | Sale 10b5-1 | −851 | $15.82 | $13K | 329,496 |
| 2024-03-18 | Kaseta Michael CFO and COO | Sale 10b5-1 | −11,315 | $15.82 | $179K | 318,181 |
| 2024-03-18 | Saggar Rajeev Chief Medical Officer | Sale 10b5-1 | −1,654 | $15.82 | $26K | 220,722 |
| 2024-03-18 | Saggar Rajeev Chief Medical Officer | Sale 10b5-1 | −5,876 | $15.82 | $93K | 214,846 |
| 2024-03-18 | JEFFS ROGER Chief Executive Officer | Sale 10b5-1 | −28,583 | $15.82 | $452K | 835,345 |
| 2024-03-15 | Adair Jason Chief Business Officer | Exercise or conversion 10b5-1 | +15,625 | 113,037 | ||
| 2024-03-15 | Adair Jason Chief Business Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −15,625 | 46,875 | ||
| 2024-03-15 | Schundler Russell General Counsel | Exercise or conversion 10b5-1 | +2,344 | 496,740 |
Page 33 of 39 · 771 trades